In May 2018, Cochrane, the research organization that bills itself as the “international gold standard for high quality, trusted information,” released a flattering review of human papillomavirus (HPV) vaccines. The Cochrane review methodology involves pulling together data from clinical trials and reviewing the assembled evidence in what is supposed to be a standardized, systematic and neutral manner. In June, we reported that Cochrane’s sources of funding—agencies and foundations that are unwilling to brook any questions about vaccine safety—raise reasonable doubts about Cochrane’s conflicts of interest and ability to remain independent from its funders’ agendas. Now, researchers affiliated with one of Cochrane’s regional member centers (the Nordic Cochrane Centre) and with the Oxford-based Centre for Evidence Based Medicine (OCEBM) have come out with an exhaustive critique of Cochrane’s HPV review, published in BMJ Evidence-Based Medicine. Not mincing their words, the authors state: "We believe that the Cochrane [HPV vaccine] review does not meet the standards for Cochrane reviews or the needs of the citizens or healthcare providers that consult Cochrane reviews to make ‘Informed decisions,’ which…is part of Cochrane’s motto." The Nordic and OCEBM authors make many solid arguments about the Cochrane reviewers’ omissions and errors, including the reviewers’ inexplicable characterization of the higher death rate in the HPV group as “a chance occurrence.”
The UK government has recently announced that, by September 2019, boys aged 12 to 13 years will be given the human papillomavirus (HPV) vaccine, a vaccine that has been available to girls in the UK for the past ten years. There has been documented evidence that the HPV vaccine has caused more injuries than any other vaccination in history. Despite this evidence, however, the HPV vaccination has continued to be hailed a success by the pharmaceutical industry and governments alike. According to the MHRA, the adverse event reporting system in the UK, there have been a total of 9,119 reports of adverse reactions reported in the UK since the vaccine was launched in 2008. These reports equate to 23,882 different ailments and include a total of 8 deaths. The UK’s decision to include boys into the equation has alarmed many parents whose daughters have already been injured by the vaccine.
A plague is spreading silently across the globe. The young generation in America, the United Kingdom, France, Italy, Japan, Australia – in virtually every western country -- is afflicted by rapidly increasing rates of infertility. This spring, the United States reported its lowest birth rate in 30 years, despite an economic boom. Finland’s birth rate plummeted to a low not seen in 150 years. Russian President Vladimir Putin recently introduced a string of reforms aimed at stemming the country’s “deep demographic declines.” The government of Denmark introduced an ad campaign to encourage couples to “Do it for Denmark” and conceive on vacations, and Poland produced a campaign urging its citizens to “breed like rabbits.” The “population bomb” we were all endlessly warned about by environmentalists failed to blow, and instead, demographers have been trying to raise the alarm about the population implosion crisis unfolding across the West -- the graying of societies facing an unprecedented aging demographic in which there will be too few young to support the old. Most often, they blame social factors: young women embracing careers instead of motherhood, men shunning marriage and fatherhood, rising consumerism or couples choosing to delay raising a family until the economy settles. But there is another phenomenon that is rarely mentioned – the growing numbers of young people who are not childless by choice but who are incapable of bearing children. So, earlier this month, when an unprecedented study was released that looked at a database of more than eight million American women and singled out a whopping 25 percent increase in childlessness associated with one particular vaccine that young women have been taking for only a decade -- in tandem with a marked decline in fecundity -- you would have thought there would be significant interest from public health, the medical profession and the media, wouldn’t you?
Gardasil Vaccine Legal Victory: Canada Federal Court Rules to Release Clinical Trial Data to American Researcher
CBC News and the British Medical Journal (BMJ) are reporting that Professor Peter Doshi has won a major legal victory against pharmaceutical companies trying to hide clinical trial data from the public due to "confidential agreements" for 5 pharmaceutical products. Doshi sued Health Canada to release clinical trial data submitted to Health Canada by the manufacturers of the HPV vaccines Gardasil, Gardasil 9 and Cervarix, and the anti-viral flu medications, Tamiflu and Relenza. A Canadian Federal Court judge ordered Health Canada to release the pharmaceutical clinical trial data, undercutting the Canadian government's attempts to keep the information confidential. As far as I can determine, this landmark court ruling out of Canada has been completely censored in the U.S. corporate-sponsored "mainstream" media. This appears to be a brilliant legal strategy by Doshi and his attorneys, since they had little to no chance of obtaining this clinical trial data from any court in the U.S., where pharmaceutical companies enjoy legal immunity from most lawsuits. The importance of receiving this data, particularly on Merck's Gardasil vaccine, cannot be overstated. As we have reported many times here at Health Impact News, the entire medical approval process to bring the HPV vaccine into the U.S. market is full of scandals and cover-ups, which has resulted in the injuries and deaths of many young people, particularly young women aged 12 to 26, many of whom can no longer bear children due to the vaccine making them infertile. "I hope my case sets a precedent and allows researchers, clinicians, and the public easy access to clinical trial data," Doshi reportedly stated in an email to CBC News. "Regulators shouldn't have a monopoly on judging the risks and benefits of medicines or hinder others from doing the same via confidentiality agreements."
Hundreds of HPV Vaccine Victims Take to the Streets in Dublin to Protest – 2 Girls Suffer Seizures During Protest
Hundreds of HPV vaccine-injured people took to the streets to protest at Leinster House, Dublin, on July 9th, 2018, while Professor Ian Frazier, one of the co-inventors of the vaccine, gave a speech next door at the Royal College of Physicians. During the protest, 3 Gardasil vaccine victims took ill, with 2 of them having seizures. Both of the girls suffering seizures had to be taken to the hospital. The following video was taken of the protest, and towards the end of the video you can see one of the girls having a seizure. This protest has been mostly censored in the "mainstream" corporate-sponsored media.
In a recent press release commemorating the 5-year anniversary of the Japanese Government suspending its recommendation of the HPV vaccine, the National Attorneys Association for the HPV Vaccines Lawsuits called upon the Japanese Government to ban the HPV vaccine completely. This is the type of news that is routinely censored in the corporate-sponsored "mainstream" media in the United States. The fact that there is a national organization of attorneys litigating against one specific vaccine and the injuries it is causing, is itself newsworthy. The vaccine manufacturers who are being sued in Japan, GlaxoSmithKline PLC and Merck Sharp & Dohme Corp., enjoy 100% legal immunity in the United States, due to the 1986 National Childhood Vaccine Injury Compensation Act. We must look outside of the U.S., therefore, to learn about just how devastating Gardasil and the HPV vaccine is, as the National Association for the HPV Vaccines Lawsuits reports: "Compared to other routine vaccinations, an average of over seven times the number of serious adverse effects per one million HPV vaccinations have been reported, and the number of disability certifications by the Adverse Drug Reaction Relief System is almost ten times higher."
Mother Faces Jury Trial As Texas Seeks to Terminate Her Parental Rights Over Daughter Injured by Gardasil Vaccine
A trial began this week for a mother who was separated from her baby after the 4-month-old mistakenly received a Gardasil-9 vaccine intended for her older brother. The Texas Department of Family and Protective Services seeks to convince a jury to terminate the parental rights of Anita Vasquez for her now 22-month-old daughter, Aniya Blu Vasquez. Jury selection began on Monday, June 18, 2018, for the trial which is expected to last up to 2 weeks. We originally reported their story in June of last year. The previously healthy baby, Aniya, began showing symptoms of problems almost immediately after getting the Gardasil shot, a vaccine which is not approved for use in children under 10 years of age. Her mother sought medical attention for the symptoms that her daughter exhibited, asking each practitioner about the connection between the symptoms and the Gardasil-9 shot that her baby should not have received, but her concerns were rebuffed at every turn. No doctor that saw her daughter wanted to admit that the vaccine could have any kind of side effects. The doctor who made a medical error in giving her the vaccine has suffered no consequences, but the baby's family has been ripped apart, as the mother is being blamed for her daughter's medical condition.
A major study has just been published in the Journal of Toxicology and Environmental Health looking at declining fertility rates among eight million U.S. women aged 25 to 29 during a 7-year period. The title of study, published by Gayle DeLong, Ph.D., from the Department of Economics and Finance, Baruch College/City University of New York, is "A lowered probability of pregnancy in females in the USA aged 25–29 who received a human papillomavirus vaccine injection." From the abstract: "This study analyzed information gathered in National Health and Nutrition Examination Survey, which represented 8 million 25-to-29-year-old women residing in the United States between 2007 and 2014. Approximately 60% of women who did not receive the HPV vaccine had been pregnant at least once, whereas only 35% of women who were exposed to the vaccine had conceived. Using logistic regression to analyze the data, the probability of having been pregnant was estimated for females who received an HPV vaccine compared with females who did not receive the shot. Results suggest that females who received the HPV shot were less likely to have ever been pregnant than women in the same age group who did not receive the shot. If 100% of females in this study had received the HPV vaccine, data suggest the number of women having ever conceived would have fallen by 2 million."
Last month (May, 2018) we published a report from the vaccine marketing trade publication, Fierce Pharma, that Merck's sales this year were beating financial forecasts, primarily due to its entrance into the China market for its top-selling Gardasil HPV vaccine. Fierce Pharma reported at that time that the Gardasil vaccine was fast-tracked for approval into the China market: "Late last month, the Chinese FDA granted Gardasil 9 a conditional approval only nine days into a review." Now, Fierce Pharma is reporting that Gardasil's acceptance into the China market has produced instant billionaires.
In Japan, young women and girls suffering from severe chronic generalized pain following vaccination with Merck’s Gardasil® or GSK’s Cervarix®, have organized and are speaking out. The issues are being debated at public hearings, at which scientific presentations have been made by independent medical experts who validated the women’s suffering with documented evidence of the severe nature of the pain related to the HPV vaccine. Such public debates do not take place where vaccine stakeholders are in full control of vaccine safety information. (Like in the U.S., for example.) Following a public hearing (February 2014), at which scientific evidence was presented by independent scientists, the Japanese government, not only rescinded its recommendation that girls receive the HPV vaccine, but established guidelines and special clinics for evaluating and treating illnesses caused by the vaccine. It is a scenario that Merck, GSK, and vaccine stakeholders globally are extremely anxious to suppress.